FTY720 prevents anti-CD4 mAb-induced tolerance but cannot reverse established tolerance in a rat kidney transplantation model

American Journal of Transplantation

Volumn 4, Issue 6, 2004, Pages 863-871

  Schroeder, Grit ^a   Risch, Kirsten ^a   Kotsch, Katja ^b   Siepert, Anja ^a   Brock, Josef ^a   Nickel, Peter ^b   Reinke, Petra ^c   Ritter, Thomas ^b   Volk, Hans Dieter ^b   Lehmann, Manfred ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NONE

Author keywords

Anti CD4 mAb; FTY720; Tolerance; Transplantation

Indexed keywords

FINGOLIMOD; OKT 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE; GRAFT SURVIVAL; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION; UREMIA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BIOPSY; CREATININE; DRUG THERAPY, COMBINATION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MODELS, ANIMAL; POLYMERASE CHAIN REACTION; PROPYLENE GLYCOLS; RATS; RATS, INBRED LEW; SPHINGOSINE; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; UREMIA;

EID: 2942627613     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00442.x     Document Type: Article

References (35)

1. Kiuchi M, Adachi K, Kohara T et al. Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720. Bioorg Med Chem Lett 1998; 8: 101-6.
2. Brinkmann V, Pinschewer DD, Feng L, Chen S. FTY720: Altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72: 764-769.
3. Boehler T, Schuetz M, Budde K, Neumayer H, Waiser J. FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients. Transplant Proc 2002; 34: 2242-2243.
4. Budde K, Schmouder RL, Brunkhorst R et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002; 13: 1073-1083.
5. Pinschewer DD, Ochsenbein AF, Odermatt B, Brinkmann V, Hengartner H, Zinkernagel RM. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory. J Immunol 2000; 164: 5761-5770.
6. Mandala S, Hajdu R, Bergstrom J et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002; 296: 346-349.
7. Brinkmann V, Davis MD, Heise CE et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277: 21453-21457.
8. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160: 5493-5499.
9. Hwang MW, Matsumori A, Furukawa Y et al. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation. Circulation 1999; 100: 1322-1329.
10. Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation 2003; 75: 945-952.
11. Schuurman HJ, Menninger K, Audet M et al. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD. Transplantation 2002; 74: 951-960.
12. Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720. Transplantation 1997; 64: 1407-1414.
13. Bai Y, Liu J, Wang Y et al. L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance. J Immunol 2002; 168: 1579-1589.
14. Lehmann M, Sternkopf F, Metz F et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992; 54: 959-962.
15. Volk HD, Siegling A, Platzer C, Brock J, Emmrich F, Lehmann M. Tolerance induction by anti-CD4 mab treatment in a rat kidney transplantation model. Transplant Proc 1994; 26: 3155-3156.
16. Lee S. An improved technique of renal transplantation in the rat. Surgery 1967; 61: 771-773.
17. Schröder G, Risch K, Nizze H et al. Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy. Transplantation 2000; 70: 191-198.
18. Sawitzki B, Kieselbach B, Fisser M et al. Interferon-gamma regulation in anti-CD4 antibody induced T cell unresponsiveness. J Am Soc Nephrol 2004; 15: 695-703.
19. Pascher A, Reutzel-Selke A, Jurisch A et al. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 2003; 76: 1560-1568.
20. Chueh SC, Tsai CC, Chiu B, Li YC, Lai MK. Rescuing acute rejection of rat cardiac allografts with FTY720, Transplant Proc 2000; 32: 1629-1630.
21. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686-693.
22. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5: 1298-1302.
23. Sho M, Sandner SE, Najafian N et al. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann Surg 2002; 236: 667-675.
24. Anselmo DM, Amersi FF, Shen XD et al. FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. Am J Transplant 2002; 2: 843-849.
25. Ke B, Ritter T, Kato H et al. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2001; 164: 5739-5745.
26. Lehmann M, Graser E, Risch K et al. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 1997; 64: 1181-1187.
27. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998; 16: 619-644.
28. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944-1950.
29. Sawitzki B, Lehmann M, Vogt K et al. Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Eur J Immunol 2002; 32: 800-809.
30. Sawitzki B, Lehmann M, Ritter T, Graser E, Kupiec-Weglinski JW, Volk HD. Regulatory tolerance-mediating T cells in transplantation tolerance. Transplant Proc 2001; 33: 2092-2093.
31. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW. Thymus requirement and antigen dependency in the 'infectious' tolerance pathway in transplant recipients. J Immunol 1998; 160: 5765-5772.
32. Budde K, Schmouder RL, Nashan B et al. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant 2003; 3: 846-854.
33. Fontenot JD, Gavin MA, Rudenski AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
34. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
35. Koshiba T, Van Damme B, Ji P et al. The effect of FTY720 on engraftment in a model of spontaneous allograft acceptance. Transpl Int 2003; 16: 383-390.